WiseTech Global claws back some ground but ASX holders still down 69% this year

WiseTech Global claws back some ground but ASX holders still down 69% this year

June 29, 2026

Sydney, June 30, 2026, 05:02 (AEST)

  • ASX cash trading hadn’t started for Tuesday yet. WiseTech last traded at A$33.82 at Monday’s close.
  • WiseTech jumped 7.2% Monday, outpacing the ASX 200’s 0.68% move and a 4.04% rise in the Information Technology sector.
  • The share price remains 68.9% lower than a year ago and trades under its June 2022 financial-year closing level.
  • Investors are selling the stock even as WiseTech sticks to its FY26 outlook for 79% to 85% revenue growth and 44% to 53% EBITDA growth.

The Australian Securities Exchange was still closed at the dateline. Pre-open is scheduled from 0700 Sydney time, and ASX normal trading gets underway at 09:59:45, the exchange said.

WiseTech Global Ltd surged Monday, jumping A$2.27, or 7.19%, to close at A$33.82. Volume hit 2.50 million shares and turnover came to A$82.8 million. But shares are still down 68.9% over the last 12 months.

WiseTech price markerPriceGap from Monday close
Monday close, June 29, 2026A$33.82
Closed at A$109.03 at end of June 2025 FYA$109.03-69.0%
Closed at A$100.30 at end of June 2024 FYA$100.30-66.3%
Closed at A$79.81 at end of June 2023 FYA$79.81-57.6%
Closed at A$37.85 at end of June 2022 FYA$37.85-10.6%
Closed at A$31.93 at end of June 2021 FYA$31.93+5.9%

The stock is back close to where it was four years ago. It would have to rise 11.9% from Monday’s close to reach the financial-year close in June 2022. To hit the June 2025 financial-year close, it needs to climb around 222%. MarketIndex tracks WiseTech’s financial-year closes for 2021 through 2025, and Monday’s ASX Top 300 movers table has the most recent finish.

Based on WiseTech’s ordinary shares quoted at 336.1 million as of April 10, a jump of A$2.27 per share on Monday lifted market cap by about A$763 million. The difference between Monday’s share price close and the expected FY2025 close stands at A$25.3 billion on the same share count. WiseTech’s April update reported 336,109,003 shares outstanding after quotation.

Monday market moveLevel/closeDay change
S&P/ASX 2008,823.4up 0.68%
All Technology index2,990.8added 3.53%
Information Technology sector1,814.9jumped 4.04%
Life360 Inc (ASX:360)A$26.27jumped 11.6%
WiseTech Global Ltd A$33.82gained 7.2%
SiteMinder Ltd (ASX:SDR)A$4.06up 5.5%
Xero Ltd A$72.18rose 4.5%

Tech drove gains. MarketIndex said the Information Technology sector led Monday, with WiseTech, Life360, SiteMinder and Xero all higher. WiseTech still has the biggest one-year drop compared with the other software stocks in the list: Xero is off 60.6% over the year, Life360 down 17.4%, SiteMinder down 9.4%.

The valuation reset is notable since WiseTech hasn’t guided like a struggling software firm. Back in February, WiseTech repeated its FY26 revenue target of $1.39 billion to $1.44 billion, with EBITDA expected between $550 million and $585 million and a margin of 40% to 41%. First-half revenue jumped 76% to $672.0 million and reported EBITDA climbed 31% to $252.1 million.

Funds are now scrutinizing the nature of that growth. WiseTech’s first-half reported EBITDA margin dropped 13 points to 38%. Statutory NPAT slid 36% to $68.1 million. Net leverage was 3.2x as of Dec. 31, after debt for the e2open buy. Free cash flow, though, rose 24% to $153.6 million.

Chief Executive Zubin Appoo said in February that the company hit results as expected. He also said the $50 million e2open annualised cost synergy target was reached in January, almost 18 months ahead of schedule.

Governance is also in focus. Reuters reported last week WiseTech shares fell more than 18% after reports executive chairman Richard White was being investigated by the Australian Federal Police. Reuters said it hadn’t verified the reports. WiseTech later told the market the media had made “no suggestion” of an investigation into the company, and said White denied any role “in or with human trafficking.” Reuters

Some analysts aren’t giving up on WiseTech’s main software asset. Shaw & Partners’ James Gerrish, quoted by Motley Fool Australia earlier this month, said WiseTech looked “more likely to be an AI beneficiary than a victim.” The same article noted Market Matters estimated 30% to 40% upside over the next 12 months. The Motley Fool Australia

Tuesday’s session matters more, since it wraps up the financial year. If WiseTech finishes below A$37.85, shares will be under where they ended June 2022, in spite of the Monday rebound and the company’s FY26 growth forecast.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Ramsay Health Care's patient transfer trial draws criticism
    June 29, 2026, 4:23 PM EDT. Ramsay Health Care is running a trial to move privately insured patients from Queensland public hospital emergency departments to its private facilities. The Emergency Department Nurse Liaison program is supposed to ease public ED pressure. Critics say it could mean 'cherrypicking' low-cost, high-turnover cases for private hospitals. Health Consumers Queensland says some patients might feel pushed toward private care. Over 2,000 patients have been moved so far. Some want the program fully reviewed before it goes national. Ramsay posted a half-year net profit of AUD 160.7 million.